SCHEMBL6710018

SCHEMBL6710018

O=C(Nc1ccc(Br)cc1-c1noc(=O)[nH]1)c1noc2ccc(-c3ccccc3F)cc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.39
GRIK1 P39086 1/20 0.39
ROCK1 Q13464 1/20 0.37
HIF1A Q16665 6/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
GPR35 Q9HC97 1/20 0.35
PTGFR P43088 1/20 0.35
F2 P00734 2/20 0.35
F10 P00742 2/20 0.35
HDAC6 Q9UBN7 2/20 0.35
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710072 0.90 HIF1A (0.45) DHODHGRIK1ROCK1HIF1AF2
SCHEMBL6711725 0.90 HIF1A (0.45) GRIK1ROCK1HIF1AMEN1KMT2A
SCHEMBL6707727 0.89 GRIK1 (0.37) GRIK1ROCK1HIF1AMEN1KMT2A
SCHEMBL6708875 0.88 DHODH (0.37) DHODHROCK1HIF1AF2F10
SCHEMBL6709887 0.87 GRIK1 (0.43) GRIK1ROCK1HIF1AMEN1KMT2A
SCHEMBL6710190 0.86 GPR35 (0.38) ROCK1HIF1AMEN1KMT2AGPR35
SCHEMBL6709940 0.86 HIF1A (0.51) GRIK1ROCK1HIF1A
SCHEMBL6709000 0.83 GRIK1 (0.40) GRIK1ROCK1HIF1AMEN1KMT2A
SCHEMBL6709925 0.83 EPHX2 (0.41) GRIK1ROCK1HIF1AMEN1KMT2A
SCHEMBL6711800 0.82 HIF1A (0.45) GRIK1ROCK1HIF1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 DHODH 107/4885GRIK1 3885/4885ROCK1 4830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.